Vident Advisory’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $39M | Buy |
50,038
+3,937
| +9% | +$3.07M | 0.44% | 50 |
|
|
2025
Q1 | $38.1M | Buy |
46,101
+13,484
| +41% | +$11.1M | 0.56% | 33 |
|
|
2024
Q4 | $25.2M | Buy |
32,617
+4,500
| +16% | +$3.47M | 0.44% | 45 |
|
|
2024
Q3 | $24.9M | Buy |
28,117
+8,586
| +44% | +$7.61M | 0.63% | 28 |
|
|
2024
Q2 | $17.7M | Buy |
19,531
+880
| +5% | +$797K | 0.49% | 38 |
|
|
2024
Q1 | $14.5M | Buy |
18,651
+1,688
| +10% | +$1.31M | 0.3% | 112 |
|
|
2023
Q4 | $9.89M | Sell |
16,963
-3,668
| -18% | -$2.14M | 0.25% | 135 |
|
|
2023
Q3 | $11.1M | Buy |
+20,631
| New | +$11.1M | 0.34% | 73 |
|